Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels

Prostate Cancer and Prostatic Diseases

Volumn 10, Issue 3, 2007, Pages 274-278

  Tanaka, N ^a   Fujimoto, K ^a   Chihara, Y ^a   Torimoto, M ^a   Hirao, Y ^a   Konishi, N ^a   Saito, I ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DISCRIMINANT ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; ONCOLOGICAL PARAMETERS; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; ROC CURVE; TRANSRECTAL ULTRASONOGRAPHY;

AREA UNDER CURVE; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; ULTRASONOGRAPHY;

EID: 34548402197     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500957     Document Type: Article

References (13)

1. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA et al. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147 815-816.
2. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate level of serum prostate specific antigen. J Urol 1992; 147: 817-821.
3. Kalish J, Cooner WH, Graham Jr SD. Serum PSA adjusted for volume of transition zone (PSAD) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994; 43: 601-606.
4. Arai Y, Maeda H, Ishitoya S, Okubo, K, Okada T, Aoki Y. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol 1997, 158: 861-864.
5. Egawa S, Suyama K, Takashima R, Mizoguchi H, Kuwao S, Baba S. Prospective evaluation of prostate cancer detection by prostate-specific antigen-related parameters. Int J Urol 1999; 6: 493-501.
6. Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998; 160: 411-419.
7. Kikuchi E, Nakashima J, Ishibashi M, Ohigashi T, Asakura H, Tachibana M et al. Prosate specific antigen adjusted for transition zone volume. Cancer 2000; 89: 842-849.
8. Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J, Saitoh M et al. Clinical significance of prostate specific antigen for early stage prostate cancer detection. Jpn J Clic Oncol 1994; 24: 160-165.
9. Matsuyama H, Baba Y, Yamanaka G, Yamamoto N, Naito K. Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer. Int J Urol 2000; 7: 409-414.
10. Maeda H, Arai Y, Aoki Y, Okubo K, Okada T, Maekawa S. Complex prostate-specific antigen and its volume indexes in the detection of prostate cancer. Urology 1999; 54: 225-228.
11. Kang SH, Bae JH, Park HS, Yoon DK, Moon DG, Kim JJ et al. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 cases. Int J Urol 2006; 13: 910-914.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology 1982; 143: 29-36.
13. Hanley JA, McNeil BJ. A method of comparing the area under receiver operating characteristic curve derived from the same cases. Radiology 1983; 148: 839-843.